A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV)
Clinical trial NCT03577171 · COMPLETED
Trial details
- NCT number
- NCT03577171
- Sponsor
- Assembly Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-19
- Primary completion
- 2019-06-21
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.